Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $98 Price Target

Author: Benzinga Newsdesk | January 31, 2024 08:47am
Rosenblatt analyst Steve Frankel reiterates Dolby Laboratories (NYSE:DLB) with a Buy and maintains $98 price target.

Posted In: DLB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist